SHPH · Shuttle Pharmaceuticals Holdings Inc
United States · RS rating 98 · As of 2026-11-03
| Price | 5.15 USD |
|---|---|
| 1-day change | +4.0% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 96 / 84 / 91 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 44 / 76 / 47 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +7.5% |
| Market cap (USD) | $5.2M |